Kazunari Tateishi
10PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Dec 10, 2024
Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression in elderly patients: a subgroup analysis of HOT/NJLCG2001.Kazunari Tateishi, Hidenori Mizugaki, Yasuyuki Ikezawa
|Dec 07, 2024
Real-World Study of EGFR-TKI Rechallenge With Another TKI After First-Line Osimertinib Discontinuation in Patients With EGFR-Mutated Non-Small Cell Lung Cancer: A Subset Analysis of the Reiwa Study.Kei Sonehara, Kazunari Tateishi, Kiyotaka Yoh
|Jan 13, 2023
C-PLAN index as a prognostic factor for patients with previously untreated advanced non-small cell lung cancer who received combination immunotherapy: A multicenter retrospective study.Kei Sonehara, Ryota Ozawa, Mineyuki Hama
|May 26, 2022
Predictive value of post-treatment C-reactive protein-to-albumin ratio in locally advanced non-small cell lung cancer patients receiving durvalumab after chemoradiotherapy.Taisuke Araki, Kazunari Tateishi, Masamichi Komatsu
|Feb 14, 2022
Association of lung immune prognostic index with survival outcome in advanced thymic carcinoma patients treated with palliative intent chemotherapy.Taisuke Araki, Kazunari Tateishi, Masamichi Komatsu
Pageof 2